Glucose Health, Inc. income statement GLUC

Annual Quarterly

It recorded a net loss of $410,443.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2017 Sep 30, 2017	FY 2016 Dec 31, 2016	FY 2015 Dec 31, 2015	FY 2014 Dec 31, 2014	FY 2013 Dec 31, 2013	FY 2012 Dec 31, 2012	FY 2011 Dec 31, 2011
Cost of revenue	0 -89.1%	0 +7488.7%	0 +47.0%	0 +13.9%	0	—	—
Gross profit	0 +205.9%	0 +4728.0%	0 +101.9%	-0 -891.2%	-0	—	—
Research and development	—	—	0 -98.8%	0	—	—	—
Selling, general and administrative	0 -74.6%	0 -54.9%	0 +604.5%	0 -58.7%	0 +584.9%	0 -60.7%	0
Operating income	-0 +57.7%	-0 +44.5%	-0 +71.4%	-1 +57.0%	-1 -251.2%	-0 +59.3%	-1
Interest expense	0 -55.0%	0 +169.8%	0 +9.5%	0 -35.1%	0 +348.4%	0 +263.0%	0
Pretax income	-0 +74.5%	-0 -54.3%	-0 +60.3%	-1 +54.1%	-1	—	—
Net income	-0 +74.5%	-0 -54.3%	-0 +60.3%	-1 +54.1%	-1 -265.6%	-0 +55.6%	-1
Basic EPS	-0.02 +82.3%	-0.15 -7.1%	-0.14 +85.9%	-0.99 +79.8%	-4.91 -9720.0%	-0.05 -150.0%	-0.02
Weighted average shares, basic	4 +44.0%	3 +42.8%	2 +189.8%	1 +127.2%	0 -96.1%	8 -79.0%	36
Other measures
Interest coverage	-0.29x	-0.27x	-1.30x	-4.97x	-7.52x	-9.60x	-85.68x

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: GLUC (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Bentonville, AR
SEC filer status: Smaller reporting company
SEC CIK: 1420108
Former names: Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.